The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Trillions of microbes exist in the human body, particularly the gastrointestinal tract, coevolved with the host in a mutually beneficial relationship. The main role of the intestinal microbiome is the fermentation of non-digestible substrates and increased growth of beneficial microbes that produce key antimicrobial metabolites such as short-chain fatty acids, etc., to inhibit the growth of pathogenic microbes besides other functions. Intestinal microbiota can prevent pathogen colonization through the mechanism of colonization resistance. A wide range of resistomes are present in both beneficial and pathogenic microbes. Giving antibiotic exposure to the intestinal microbiome (both beneficial and hostile) can trigger a resistome response, affecting colonization resistance. The following review provides a mechanistic overview of the intestinal microbiome and the impacts of antibiotic therapy on pathogen colonization and diseases. Further, we also discuss the epidemiology of immunocompromised patients who are at high risk for nosocomial infections, colonization and decolonization of multi-drug resistant organisms in the intestine, and the direct and indirect mechanisms that govern colonization resistance to the pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics can disrupt the normal gut microbiota, creating an environment conducive to S. aureus colonization. This disruption reduces microbial competition, allowing S. aureus, including MRSA, to establish itself in the GI tract [71].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proteobacteria: Microbial signature of dysbiosis in gut microbiota
Shin, N.-R., Whon, T. W., & Bae, J.-W. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.011 · Cited by 3,954
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Mechanisms Regulating Intestinal Barrier Integrity and Its Pathological Implications
Chelakkot, C., Ghim, J., & Ryu, S. H. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0126-x · Cited by 2,017
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Antibiotics, birth mode, and diet shape microbiome maturation during early life
Bokulich, N. A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., D. Lieber, A., Wu, F., Perez-Perez, G. I., Chen, Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7121 · Cited by 1,469
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
The first 1000 cultured species of the human gastrointestinal microbiota
Rajilić-Stojanović, M., & de Vos, W. M. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12075 · Cited by 1,182
Yassour, M., Vatanen, T., Siljander, H., Hämäläinen, A.-M., Härkönen, T., Ryhänen, S. J., Franzosa, E. A., Vlamakis, H., Huttenhower, C., Gevers, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0917 · Cited by 1,043
Research works printed but not linked: 133
- Ursell, 2012, Defining the human microbiome, Nutr. Rev., 70, S38, 10.1111/j.1753-4887.2012.00493.x · DOI · Paper page
- Baghbani, 2020, Dual and mutual interaction between microbiota and viral infections: A possible treat for COVID-19, Microb. Cell Fact., 19, 217, 10.1186/s12934-020-01483-1 · DOI
- Fernandes, 2019, Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1876, 10.1016/j.bbadis.2018.09.032 · DOI · Paper page
- Kumar Singh, A., Cabral, C., Kumar, R., Ganguly, R., Kumar Rana, H., Gupta, A., Rosaria Lauro, M., Carbone, C., Reis, F., and Pandey, A.K. (2019). Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency. Nutrients, 11. · DOI · Paper page
- McFarland, 2008, Antibiotic-associated diarrhea: Epidemiology, trends and treatment, Future Microbiol., 3, 563, 10.2217/17460913.3.5.563 · DOI · Paper page
- Beaugerie, 2003, Antibiotic-associated diarrhoea and Clostridium difficile in the community, Aliment. Pharmacol. Ther., 17, 905, 10.1046/j.1365-2036.2003.01531.x · DOI
- Ramirez, 2020, Antibiotics as Major Disruptors of Gut Microbiota, Front. Cell. Infect. Microbiol., 10, 572912, 10.3389/fcimb.2020.572912 · DOI · Paper page
- Szajewska, 2016, Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children, J. Pediatr. Gastroenterol. Nutr., 62, 495, 10.1097/MPG.0000000000001081 · DOI · Paper page
- Alonso, 2013, Clostridium difficile infection among hematopoietic stem cell transplant recipients: Beyond colitis, Curr. Opin. Infect. Dis., 26, 326, 10.1097/QCO.0b013e3283630c4c · DOI
- Alyousef, 2018, Clostridium difficile: Epidemiology, Pathogenicity, and an Update on the Limitations of and Challenges in Its Diagnosis, J. AOAC Int., 101, 1119, 10.5740/jaoacint.17-0352 · DOI
- Ofori, 2018, Community-acquired Clostridium difficile: Epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies, J. Hosp. Infect., 99, 436, 10.1016/j.jhin.2018.01.015 · DOI
- Leffler, 2015, Clostridium difficile infection, N. Engl. J. Med., 372, 1539, 10.1056/NEJMra1403772 · DOI · Paper page
- Malfertheiner, 2017, Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, Gut, 66, 6, 10.1136/gutjnl-2016-312288 · DOI · Paper page
- Li, 2017, Alterations in Gastric Microbiota after H. Pylori Eradication and in Different Histological Stages of Gastric Carcinogenesis, Sci. Rep., 7, 44935, 10.1038/srep44935 · DOI · Paper page
- Yap, T.W., Gan, H.M., Lee, Y.P., Leow, A.H., Azmi, A.N., Francois, F., Perez-Perez, G.I., Loke, M.F., Goh, K.L., and Vadivelu, J. (2016). Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults. PLoS ONE, 11. · DOI
- Szajewska, 2015, Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults, Aliment. Pharmacol. Ther., 42, 1149, 10.1111/apt.13404 · DOI · Paper page
- Losurdo, 2018, Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis, World J. Gastroenterol., 24, 139, 10.3748/wjg.v24.i1.139 · DOI
- Kronman, 2012, Antibiotic exposure and IBD development among children: A population-based cohort study, Pediatrics, 130, e794, 10.1542/peds.2011-3886 · DOI · Paper page
- Vergara, 2018, Intestinal microbiota and antibiotic resistance: Perspectives and solutions, Hum. Microbiome J., 9, 11, 10.1016/j.humic.2018.05.002 · DOI
- Baron, S.A., Diene, S.M., and Rolain, J.-M. (2018). Human microbiomes and antibiotic resistance. Hum. Microbiome J., 10. · DOI
- Penders, 2013, The human microbiome as a reservoir of antimicrobial resistance, Front. Microbiol., 4, 87, 10.3389/fmicb.2013.00087 · DOI · Paper page
- Spigaglia, 2016, Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection, Ther. Adv. Infect. Dis., 3, 23
- Tang, 2016, The incidence and drug resistance of Clostridium difficile infection in Mainland China: A systematic review and meta-analysis, Sci. Rep., 6, 37865, 10.1038/srep37865 · DOI
- Isidro, 2018, Genomic Study of a Clostridium difficile Multidrug Resistant Outbreak-Related Clone Reveals Novel Determinants of Resistance, Front. Microbiol., 9, 2994, 10.3389/fmicb.2018.02994 · DOI
- Kachrimanidou, M., and Tsintarakis, E. (2020). Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection. Microorganisms, 8. · DOI
- Gorrie, 2017, Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients, Clin. Infect. Dis., 65, 208, 10.1093/cid/cix270 · DOI · Paper page
- Stercz, 2021, The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15, Sci. Rep., 11, 6335, 10.1038/s41598-021-85766-6 · DOI
- Patriarca, 2017, Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation, Biol. Blood Marrow Transplant., 23, 333, 10.1016/j.bbmt.2016.11.005 · DOI
- Macesic, 2018, Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients, Clin. Infect. Dis., 67, 905, 10.1093/cid/ciy199 · DOI
- 2015, The human gut resistome, Philos. Trans. R. Soc. Lond. B Biol. Sci., 370, 20140087, 10.1098/rstb.2014.0087 · DOI · Paper page
- Zhang, 2019, Facing a new challenge: The adverse effects of antibiotics on gut microbiota and host immunity, Chin. Med. J., 132, 1135, 10.1097/CM9.0000000000000245 · DOI
- Bui, 2019, Association between periodontal pathogens and systemic disease, Biomed. J., 42, 27, 10.1016/j.bj.2018.12.001 · DOI · Paper page
- Dutta, 2020, Bidirectional interaction between intestinal microbiome and cancer: Opportunities for therapeutic interventions, Biomark. Res., 8, 31, 10.1186/s40364-020-00211-6 · DOI
- Noor, 2019, The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials, J. Innate Immun., 11, 405, 10.1159/000492943 · DOI
- Vermeulen, 2019, Stem cells in homeostasis and cancer of the gut, Mol. Cancer, 18, 66, 10.1186/s12943-019-0962-x · DOI
- Kim, 2017, The interplay between host immune cells and gut microbiota in chronic inflammatory diseases, Exp. Mol. Med., 49, e339, 10.1038/emm.2017.24 · DOI · Paper page
- Kwon, 2016, Mechanism-based management for mucositis: Option for treating side effects without compromising the efficacy of cancer therapy, Onco Targets Ther., 9, 2007, 10.2147/OTT.S96899 · DOI
- Cassidy, 2020, Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia through Mathematical Modelling, Bull. Math. Biol., 82, 104, 10.1007/s11538-020-00777-0 · DOI
- Shogbesan, 2018, A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients, Can. J. Gastroenterol. Hepatol., 2018, 1394379, 10.1155/2018/1394379 · DOI · Paper page
- Wendt, 2014, Clostridium difficile infection among children across diverse US geographic locations, Pediatrics, 133, 651, 10.1542/peds.2013-3049 · DOI
- Hourigan, 2014, The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease, Dig. Dis. Sci., 59, 2222, 10.1007/s10620-014-3169-4 · DOI
- Sunkersett, 2017, Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients, Biol. Blood Marrow Transplant., 23, 820, 10.1016/j.bbmt.2017.02.004 · DOI · Paper page
- Jouhten, 2016, Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients with Recurrent Clostridium difficile Infection after Fecal Microbiota Transplantation, Clin. Infect. Dis., 63, 710, 10.1093/cid/ciw390 · DOI · Paper page
- Millan, 2016, Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients with Recurrent Clostridium difficile Infection, Clin. Infect. Dis., 62, 1479, 10.1093/cid/ciw185 · DOI · Paper page
- Leung, 2018, Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection, Clin. Infect. Dis., 66, 456, 10.1093/cid/cix821 · DOI
- Schmid, H., Romanos, A., Schiffl, H., and Lederer, S.R. (2013). Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: A predictor of worse outcome. BMC Nephrol., 14. · DOI
- Prematunge, 2016, VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis, Infect. Control. Hosp. Epidemiol., 37, 26, 10.1017/ice.2015.228 · DOI · Paper page
- Huttner, 2013, Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: A randomized, double-blind, placebo-controlled trial, J. Antimicrob. Chemother., 68, 2375
- Lawley, 2013, Intestinal colonization resistance, Immunology, 138, 1, 10.1111/j.1365-2567.2012.03616.x · DOI · Paper page
- Caballero, 2017, Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium, Cell Host Microbe, 21, 592, 10.1016/j.chom.2017.04.002 · DOI · Paper page
- Becattini, 2017, Commensal microbes provide first line defense against Listeria monocytogenes infection, J. Exp. Med., 214, 1973, 10.1084/jem.20170495 · DOI · Paper page
- Kommineni, 2015, Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract, Nature, 526, 719, 10.1038/nature15524 · DOI · Paper page
- Mahieu, 2017, Impact of faecal microbiota transplantation on mouse digestive colonization with two extensively resistant bacteria, J. Infect., 75, 75, 10.1016/j.jinf.2017.04.008 · doi:10.1016/j.jinf.2017.04.008
- Gosalbes, 2016, Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community, Antimicrob. Agents Chemother., 60, 507, 10.1128/AAC.01528-15 · DOI
- Pickard, 2019, Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health, Am. J. Pathol., 189, 1300, 10.1016/j.ajpath.2019.03.003 · DOI
- Cascales, 2007, Colicin biology, Microbiol. Mol. Biol. Rev., 71, 158, 10.1128/MMBR.00036-06 · DOI · Paper page
- Mayer, 2019, Gut microbiota as a source of novel antimicrobials, Gut Microbes, 10, 1, 10.1080/19490976.2018.1455790 · DOI · Paper page
- Gillor, O., Giladi, I., and Riley, M.A. (2009). Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract. BMC Microbiol., 9. · DOI
- Umu, Ö.C., Bäuerl, C., Oostindjer, M., Pope, P.B., Hernández, P.E., Pérez-Martínez, G., and Diep, D.B. (2016). The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health. PLoS ONE, 11. · DOI
- Lamas, A., Regal, P., Vázquez, B., Cepeda, A., and Franco, C.M. (2019). Short Chain Fatty Acids Commonly Produced by Gut Microbiota Influence Salmonella enterica Motility, Biofilm Formation, and Gene Expression. Antibiotics, 8. · DOI
- Leatham, 2009, Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine, Infect. Immun., 77, 2876, 10.1128/IAI.00059-09 · DOI · Paper page
- Brown, J.R., Flemer, B., Joyce, S.A., Zulquernain, A., Sheehan, D., Shanahan, F., and O’Toole, P.W. (2018). Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. BMC Gastroenterol., 18. · DOI
- Vincent, 2015, Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection, Antibiotics, 4, 230, 10.3390/antibiotics4030230 · DOI
- Staels, 2009, Bile acids and metabolic regulation: Mechanisms and clinical responses to bile acid sequestration, Diabetes Care, 32, S237, 10.2337/dc09-S355 · DOI · Paper page
- Ajouz, 2014, Secondary bile acids: An underrecognized cause of colon cancer, World J. Surg. Oncol., 12, 164, 10.1186/1477-7819-12-164 · DOI · Paper page
- 2018, Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction, Biotechnol. Adv., 36, 682, 10.1016/j.biotechadv.2017.12.005 · DOI
- Kochan, T.J., Shoshiev, M.S., Hastie, J.L., Somers, M.J., Plotnick, Y.M., Gutierrez-Munoz, D.F., Foss, E.D., Schubert, A.M., Smith, A.D., and Zimmerman, S.K. (2018). Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions. mSphere, 3. · DOI
- Nie, 2015, Cross-talk between bile acids and intestinal microbiota in host metabolism and health, J. Zhejiang Univ. Sci. B, 16, 436, 10.1631/jzus.B1400327 · DOI
- Martin, 2018, In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota, Front. Microbiol., 9, 1153, 10.3389/fmicb.2018.01153 · DOI
- Kong, 2018, Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids, Biomed. Res. Int., 2018, 2819154, 10.1155/2018/2819154 · DOI · Paper page
- Huang, 2011, The human commensal Bacteroides fragilis binds intestinal mucin, Anaerobe, 17, 137, 10.1016/j.anaerobe.2011.05.017 · DOI · Paper page
- Kinoshita, 2007, Quantitative evaluation of adhesion of lactobacilli isolated from human intestinal tissues to human colonic mucin using surface plasmon resonance (BIACORE assay), J. Appl. Microbiol., 102, 116, 10.1111/j.1365-2672.2006.03061.x · DOI · Paper page
- Sicard, 2017, Interactions of Intestinal Bacteria with Components of the Intestinal Mucus, Front. Cell. Infect. Microbiol., 7, 387, 10.3389/fcimb.2017.00387 · DOI · Paper page
- Iacob, 2018, Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats, Front. Microbiol., 9, 3328, 10.3389/fmicb.2018.03328 · DOI · Paper page
- 2016, Bifidobacteria and Their Role as Members of the Human Gut Microbiota, Front. Microbiol., 7, 925
- Logan, 2018, The Vibrio cholerae type VI secretion system can modulate host intestinal mechanics to displace gut bacterial symbionts, Proc. Natl. Acad. Sci. USA, 115, E3779, 10.1073/pnas.1720133115 · DOI · Paper page
- Wu, 2020, Type III Secretion 1 Effector Gene Diversity Among Vibrio Isolates from Coastal Areas in China, Front. Cell. Infect. Microbiol., 10, 301, 10.3389/fcimb.2020.00301 · DOI
- Bierne, 2008, Listeria monocytogenes internalins bind to the human intestinal mucin MUC2, Arch. Microbiol., 190, 101, 10.1007/s00203-008-0358-6 · DOI
- Rehman, 2019, Adhesive mechanism of different Salmonella fimbrial adhesins, Microb. Pathog., 137, 103748, 10.1016/j.micpath.2019.103748 · DOI
- Ferreyra, 2014, Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance, Cell Host Microbe, 16, 770, 10.1016/j.chom.2014.11.003 · DOI · Paper page
- Coyne, 2005, Human symbionts use a host-like pathway for surface fucosylation, Science, 307, 1778, 10.1126/science.1106469 · DOI · Paper page
- Wands, 2015, Fucosylation and protein glycosylation create functional receptors for cholera toxin, eLife, 4, e09545, 10.7554/eLife.09545 · DOI · Paper page
- Dwivedi, 2016, L-fucose influences chemotaxis and biofilm formation in Campylobacter jejuni, Mol. Microbiol., 101, 575, 10.1111/mmi.13409 · DOI
- Sicard, 2018, N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli, Gut Pathog., 10, 26, 10.1186/s13099-018-0252-y · DOI
- Schumann, 2012, Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model, Appl. Environ. Microbiol., 78, 1513, 10.1128/AEM.07340-11 · DOI
- Thiennimitr, 2011, Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota, Proc. Natl. Acad. Sci. USA, 108, 17480, 10.1073/pnas.1107857108 · DOI · Paper page
- Kamada, 2012, Regulated virulence controls the ability of a pathogen to compete with the gut microbiota, Science, 336, 1325, 10.1126/science.1222195 · DOI · Paper page
- Massip, 2020, Siderophore-Microcins in Escherichia coli: Determinants of Digestive Colonization, the First Step Toward Virulence, Front. Cell. Infect. Microbiol., 10, 381, 10.3389/fcimb.2020.00381 · DOI
- Lasaro, 2009, F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917, Appl. Environ. Microbiol., 75, 246, 10.1128/AEM.01144-08 · DOI
- Nissle, 1961, Old and new experiences on therapeutic successes by restoration of the colonic flora with mutaflor in gastrointestinal diseases, Med. Welt, 29-30, 1519
- Kim, 2020, Recent insights into cellular crosstalk in respiratory and gastrointestinal mucosal immune systems, Immune Netw., 20, e44, 10.4110/in.2020.20.e44 · DOI
- Petersson, 2011, Importance and regulation of the colonic mucus barrier in a mouse model of colitis, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G327, 10.1152/ajpgi.00422.2010 · DOI · Paper page
- Muzaki, 2017, Long-Lived Innate IL-17-Producing γ/δ T Cells Modulate Antimicrobial Epithelial Host Defense in the Colon, J. Immunol., 199, 3691, 10.4049/jimmunol.1701053 · DOI
- Cobo, 2013, Antimicrobial Human β-Defensins in the Colon and Their Role in Infectious and Non-Infectious Diseases, Pathogens, 2, 177, 10.3390/pathogens2010177 · DOI
- Dutta, 2016, Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation, Curr. Top. Med. Chem., 16, 99, 10.2174/1568026615666150703121819 · DOI
- Fusco, 2017, Beta-Defensin-2 and Beta-Defensin-3 Reduce Intestinal Damage Caused by Salmonella typhimurium Modulating the Expression of Cytokines and Enhancing the Probiotic Activity of Enterococcus faecium, J. Immunol. Res., 2017, 6976935, 10.1155/2017/6976935 · DOI
- Diamond, 2009, The roles of antimicrobial peptides in innate host defense, Curr. Pharm. Des., 15, 2377, 10.2174/138161209788682325 · DOI · Paper page
- Ayabe, 2000, Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria, Nat. Immunol., 1, 113, 10.1038/77783 · DOI · Paper page
- Sugi, 2017, α-Defensin 5 gene expression is regulated by gut microbial metabolites, Biosci. Biotechnol. Biochem., 81, 242, 10.1080/09168451.2016.1246175 · DOI
- Menendez, 2013, Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell α-defensins, J. Innate Immun., 5, 39, 10.1159/000341630 · DOI
- Miani, 2018, Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes, Cell Metab., 28, 557, 10.1016/j.cmet.2018.06.012 · DOI · Paper page
- Yi, 2017, Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection, J. Immunol., 198, 1696, 10.4049/jimmunol.1601221 · DOI
- Ju, T., Shoblak, Y., Gao, Y., Yang, K., Fouhse, J., Finlay, B.B., So, Y.W., Stothard, P., and Willing, B.P. (2017). Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli. Appl. Environ. Microbiol., 83. · DOI
- Thomas, M., Pierson, M., Uprety, T., Zhu, L., Ran, Z., Sreenivasan, C.C., Wang, D., Hause, B., Francis, D.H., and Li, F. (2018). Comparison of Porcine Airway and Intestinal Epithelial Cell Lines for the Susceptibility and Expression of Pattern Recognition Receptors upon Influenza Virus Infection. Viruses, 10. · DOI
- Vaishnava, 2011, The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine, Science, 334, 255, 10.1126/science.1209791 · DOI · Paper page
- Zheng, 2008, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat. Med., 14, 282, 10.1038/nm1720 · DOI · Paper page
- Mukherjee, 2015, Antimicrobial defense of the intestine, Immunity, 42, 28, 10.1016/j.immuni.2014.12.028 · DOI · Paper page
- Dessein, 2009, Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis, Gut, 58, 771, 10.1136/gut.2008.168443 · DOI · Paper page
- Burger-van Paassen, N., Loonen, L.M., Witte-Bouma, J., Korteland-van Male, A.M., de Bruijn, A.C., van der Sluis, M., Lu, P., Van Goudoever, J.B., Wells, J.M., and Dekker, J. (2012). Mucin Muc2 deficiency and weaning influences the expression of the innate defense genes Reg3β, Reg3γ and angiogenin-4. PLoS ONE, 7. · DOI
- Valentini, 2014, Immunomodulation by gut microbiota: Role of Toll-like receptor expressed by T cells, J. Immunol. Res., 2014, 586939, 10.1155/2014/586939 · DOI
- Larsson, 2012, Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88, Gut, 61, 1124, 10.1136/gutjnl-2011-301104 · DOI · Paper page
- Tyler, 2017, Antigen-Presenting Human γδ T Cells Promote Intestinal CD4(+) T Cell Expression of IL-22 and Mucosal Release of Calprotectin, J. Immunol., 198, 3417, 10.4049/jimmunol.1700003 · DOI
- Xu, 2014, Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia, J. Immunol., 192, 1778, 10.4049/jimmunol.1300039 · DOI
- Ota, 2011, IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium, Nat. Immunol., 12, 941, 10.1038/ni.2089 · DOI · Paper page
- Sellau, 2016, IL-22 dampens the T cell response in experimental malaria, Sci. Rep., 6, 28058, 10.1038/srep28058 · DOI
- Behnsen, 2014, The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria, Immunity, 40, 262, 10.1016/j.immuni.2014.01.003 · DOI · Paper page
- Murray, 2017, Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis, Curr. Opin. Toxicol., 2, 15, 10.1016/j.cotox.2017.01.003 · DOI
- Gao, 2018, Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism, Front. Cell. Infect. Microbiol., 8, 13, 10.3389/fcimb.2018.00013 · DOI · Paper page
- Yitbarek, 2018, Gut microbiota-mediated protection against influenza virus subtype H9N2 in chickens is associated with modulation of the innate responses, Sci. Rep., 8, 13189, 10.1038/s41598-018-31613-0 · DOI
- Chassaing, 2017, Tryptophan: A gut microbiota-derived metabolites regulating inflammation, World J. Gastrointest. Pharmacol. Ther., 8, 7, 10.4292/wjgpt.v8.i1.7 · DOI · Paper page
- Krishnan, 2018, Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis, Proc. Natl. Acad. Sci. USA, 115, 10738, 10.1073/pnas.1802320115 · DOI
- Duan, 2010, Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells, Cell Host Microbe, 7, 140, 10.1016/j.chom.2010.01.005 · DOI · Paper page
- Ueda, 2010, Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10, Int. Immunol., 22, 953, 10.1093/intimm/dxq449 · DOI
- Hayashi, 2013, A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice, Cell Host Microbe, 13, 711, 10.1016/j.chom.2013.05.013 · DOI · Paper page
- Morhardt, 2019, IL-10 produced by macrophages regulates epithelial integrity in the small intestine, Sci. Rep., 9, 1223, 10.1038/s41598-018-38125-x · DOI
- Ochi, 2016, Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine, Sci. Rep., 6, 27634, 10.1038/srep27634 · DOI
- Pallav, 2014, Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: A randomized clinical trial, Gut Microbes, 5, 458, 10.4161/gmic.29558 · DOI
- Abeles, 2016, Microbial diversity in individuals and their household contacts following typical antibiotic courses, Microbiome, 4, 39, 10.1186/s40168-016-0187-9 · DOI · Paper page
- Engelbrektson, 2009, Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy, J. Med. Microbiol., 58, 663, 10.1099/jmm.0.47615-0 · DOI · Paper page
- Stewardson, 2015, Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: A culture-free analysis of gut microbiota, Clin. Microbiol. Infect., 21, 344.e341, 10.1016/j.cmi.2014.11.016 · DOI
- Vervoort, 2015, Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota, J. Antimicrob. Chemother., 70, 1989, 10.1093/jac/dkv062 · DOI
- Maukonen, 2008, Influence of oral doxycycline therapy on the diversity and antibiotic susceptibility of human intestinal bifidobacterial population, J. Appl. Microbiol., 105, 279, 10.1111/j.1365-2672.2008.03792.x · DOI
- Rashid, 2013, Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora, Int. J. Antimicrob. Agents, 41, 352, 10.1016/j.ijantimicag.2012.11.014 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Shah, T., Baloch, Z., Shah, Z., Cui, X., & Xia, X.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-20
- Volume
- 22
- Issue
- 12
- Pages
- 6597
- ISSN
- 1422-0067
- Cited by
- 106
- References
- 43
- Language
- en
- Funders
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (U1702282)
- the major science and technology special project of Yunnan Province (2019F004)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. https://app.cochat.ai/papers/10.3390/ijms22126597
- The paper
- Shah, T., Baloch, Z., Shah, Z., Cui, X., & Xia, X. (2021). The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22126597
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.